Surveillance procedures for patients treated for endometrial cancer: A review of the literature

Enrico Sartori, Brunella Pasinetti, Francesca Chiudinelli, Angiolo Gadducci, Fabio Landoni, Tiziano Maggino, Elisa Piovano, Paolo Zola

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.

Original languageEnglish
Pages (from-to)985-992
Number of pages8
JournalInternational Journal of Gynecological Cancer
Volume20
Issue number6
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Endometrial Neoplasms
Recurrence
Neoplasms
Asymptomatic Diseases
Gynecological Examination
MEDLINE
Physical Examination
Cost-Benefit Analysis
Early Diagnosis
Thorax
Databases
Guidelines
Breast Neoplasms
Morbidity
Survival
Mortality

Keywords

  • Endometrial Cancer
  • Follow-up
  • Procedures

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Medicine(all)

Cite this

Sartori, E., Pasinetti, B., Chiudinelli, F., Gadducci, A., Landoni, F., Maggino, T., ... Zola, P. (2010). Surveillance procedures for patients treated for endometrial cancer: A review of the literature. International Journal of Gynecological Cancer, 20(6), 985-992. https://doi.org/10.1111/IGC.0b013e3181e2abcc

Surveillance procedures for patients treated for endometrial cancer : A review of the literature. / Sartori, Enrico; Pasinetti, Brunella; Chiudinelli, Francesca; Gadducci, Angiolo; Landoni, Fabio; Maggino, Tiziano; Piovano, Elisa; Zola, Paolo.

In: International Journal of Gynecological Cancer, Vol. 20, No. 6, 08.2010, p. 985-992.

Research output: Contribution to journalArticle

Sartori, E, Pasinetti, B, Chiudinelli, F, Gadducci, A, Landoni, F, Maggino, T, Piovano, E & Zola, P 2010, 'Surveillance procedures for patients treated for endometrial cancer: A review of the literature', International Journal of Gynecological Cancer, vol. 20, no. 6, pp. 985-992. https://doi.org/10.1111/IGC.0b013e3181e2abcc
Sartori, Enrico ; Pasinetti, Brunella ; Chiudinelli, Francesca ; Gadducci, Angiolo ; Landoni, Fabio ; Maggino, Tiziano ; Piovano, Elisa ; Zola, Paolo. / Surveillance procedures for patients treated for endometrial cancer : A review of the literature. In: International Journal of Gynecological Cancer. 2010 ; Vol. 20, No. 6. pp. 985-992.
@article{f42d49f5e5494796a5d957561e175d25,
title = "Surveillance procedures for patients treated for endometrial cancer: A review of the literature",
abstract = "Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words {"}endometrial neoplasms{"} and {"}follow up{"}. Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13{\%} and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.",
keywords = "Endometrial Cancer, Follow-up, Procedures",
author = "Enrico Sartori and Brunella Pasinetti and Francesca Chiudinelli and Angiolo Gadducci and Fabio Landoni and Tiziano Maggino and Elisa Piovano and Paolo Zola",
year = "2010",
month = "8",
doi = "10.1111/IGC.0b013e3181e2abcc",
language = "English",
volume = "20",
pages = "985--992",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Surveillance procedures for patients treated for endometrial cancer

T2 - A review of the literature

AU - Sartori, Enrico

AU - Pasinetti, Brunella

AU - Chiudinelli, Francesca

AU - Gadducci, Angiolo

AU - Landoni, Fabio

AU - Maggino, Tiziano

AU - Piovano, Elisa

AU - Zola, Paolo

PY - 2010/8

Y1 - 2010/8

N2 - Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.

AB - Objectives: The aim of this review was to analyze the role of follow-up in patients treated for endometrial cancer and to provide some compelling issues that may contribute to improve daily practice while waiting for evidence-based guidelines. Methods/Materials: A literature search has been conducted in MEDLINE database using key words "endometrial neoplasms" and "follow up". Results: Endometrial cancer represents the most common gynecologic malignancy after breast cancer. The overall recurrence rate is 13% and correlates with prognostic factors of the primary tumor. The anatomic sites of endometrial cancer relapse are mostly equivalently distributed between local (pelvic) and distant (abdominal and chest). Most endometrial cancer recurrences are symptomatic, even if vaginal vault relapses represent a particular setting of a more frequently asymptomatic disease. Most of endometrial cancer recurrences occur within 3 years since diagnosis of primary tumor. Long-term surveillance programs are mainly addressed to the early detection of recurrence, the rationale of follow-up being that an earlier diagnosis of relapse correlates with lower morbidity and mortality rates. Adjunctive objectives of routine follow-up are identification of treatment complications and detection of possible second tumors associated with endometrial cancer. Conclusions: No rationale (examination sensitivity/sensibility, cost-effectiveness, or patient's survival benefit) is available today for any particular follow-up protocol; follow-up procedures should probably be tailored according to different prognostic factors; only physical examination, including pelvic-rectal examination, showed some utility in detecting recurrence. In this uncertain setting, follow-up interval should be defined with the consideration of the patient's will.

KW - Endometrial Cancer

KW - Follow-up

KW - Procedures

UR - http://www.scopus.com/inward/record.url?scp=77956829833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956829833&partnerID=8YFLogxK

U2 - 10.1111/IGC.0b013e3181e2abcc

DO - 10.1111/IGC.0b013e3181e2abcc

M3 - Article

C2 - 20683406

AN - SCOPUS:77956829833

VL - 20

SP - 985

EP - 992

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 6

ER -